Exane Derivatives’s Vanguard Intermediate-Term Bond ETF BIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-750
Closed -$61.4K 809
2022
Q1
$61.4K Buy
+750
New +$63.3K 0.02% 546
2021
Q4
Sell
-750
Closed -$67.1K 886
2021
Q3
$67.1K Hold
750
0.02% 590
2021
Q2
$67.6K Buy
+750
New +$67K 0.02% 595

Other funds holding BIV

Exane Derivatives's BIV Position: Q2 2022 in Review

Exane Derivatives sold out of Vanguard Intermediate-Term Bond ETF (BIV) in Q2 2022, closing a stake of 750 shares — an estimated $61.4K sold.

Exane Derivatives first reported a position in BIV in Q2 2021 and held it in 3 quarters. The position peaked at $67.6K in Q2 2021. 673 funds tracked by Wall St. Rank hold BIV as of Q2 2022.

  • Exane Derivatives reported no remaining Vanguard Intermediate-Term Bond ETF position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 750 Vanguard Intermediate-Term Bond ETF shares in Q2 2022, an estimated $61.4K.
  • Exane Derivatives first reported a position in Vanguard Intermediate-Term Bond ETF in Q2 2021 and held it in 3 quarters.
  • Exane Derivatives's Vanguard Intermediate-Term Bond ETF position peaked at $67.6K in Q2 2021.
  • 673 funds tracked by Wall St. Rank held Vanguard Intermediate-Term Bond ETF as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.